Clinical Trials

Expanded Access (Compassionate Use) Treatment Protocol: Rindopepimut (CDX-110)


Study ID
Celldex Compassionate Use CDX110-05

Research Study Number
00005674

Principle Investigator
Dr. Samuel Singer

Sponsor
Celldex Therapeutics, Inc.


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now